MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$26,655K
Unrealized gain (loss) on
defined benefit pension...
-$219K
Net loss
-$25,546K
Foreign currency
translation (loss) gain
-$945K
Unrealized (loss) gain on
marketable debt securities
-$383K
Income (loss) from
discontinued operations, net...
$24,715K
Loss from continuing
operations, net of tax
-$50,261K
Interest income
$12,721K
Other income
(expense), net
$11,578K
Loss from continuing
operations before income...
-$49,273K
Income tax provision on
continuing operations
$988K
Total other income,
net
$13,551K
Interest expense
$10,748K
Operating loss
-$62,824K
Total
revenue-Product
$410,460K
Total
revenue-License
$80,268K
Total operating
expenses
$553,552K
Selling, general and
administrative
$337,202K
Research and development
$206,011K
Cost of goods sold
$10,339K
Product
$5,813K
License
$4,526K
Back
Back
Income Statement
source: myfinsight.com
Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. (TVTX)